These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16762046)

  • 1. Variation in the RAD51 gene and familial breast cancer.
    Lose F; Lovelock P; Chenevix-Trench G; Mann GJ; Pupo GM; Spurdle AB;
    Breast Cancer Res; 2006; 8(3):R26. PubMed ID: 16762046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
    Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland.
    Jakubowska A; Narod SA; Goldgar DE; Mierzejewski M; Masojć B; Nej K; Huzarska J; Byrski T; Górski B; Lubiński J
    Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):457-9. PubMed ID: 12750242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
    Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
    Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCoR-L1 variation and breast cancer.
    Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
    Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.
    Rapakko K; Heikkinen K; Karppinen SM; Winqvist R
    Cancer Lett; 2006 May; 236(1):142-7. PubMed ID: 16005565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
    Cousineau I; Abaji C; Belmaaza A
    Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Rad51 alteration in patients with bilateral breast cancer.
    Kato M; Yano K; Matsuo F; Saito H; Katagiri T; Kurumizaka H; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nagawa H; Nakamura Y; Miki Y
    J Hum Genet; 2000; 45(3):133-7. PubMed ID: 10807537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
    Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
    Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
    Söderlund K; Skoog L; Fornander T; Askmalm MS
    Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
    Lewis AG; Flanagan J; Marsh A; Pupo GM; Mann G; Spurdle AB; Lindeman GJ; Visvader JE; Brown MA; Chenevix-Trench G;
    Breast Cancer Res; 2005; 7(6):R1005-16. PubMed ID: 16280053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
    Romanowicz-Makowska H; Smolarz B; Kulig A
    Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.
    Romanowicz-Makowska H; Smolarz B; Zadrozny M; Kulig A
    Exp Oncol; 2006 Jun; 28(2):156-9. PubMed ID: 16837909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
    Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
    Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
    Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
    Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
    Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair gene expression and risk of locoregional relapse in breast cancer patients.
    Le Scodan R; Cizeron-Clairac G; Fourme E; Meseure D; Vacher S; Spyratos F; de la Lande B; Cvitkovic F; Lidereau R; Bieche I
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):328-36. PubMed ID: 20092964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.